Prediction: NuScale Power Stock Doesn't Get Halfway Back to Its Old High Before 2029

NuScale Power trades near $10.81, 81% below its $57.42 52-week high, and would need to rise roughly 166% to $28.71 by end-2028—equivalent to about 53% annualized growth. Q2 2026 revenue collapsed 99% year over year to $75,000 while net loss widened to $50.1 million from $37.6 million, although the company held $1.9 billion in cash and investments. A potential TVA/ENTRA1 binding power-purchase agreement could support the shares but would trigger approximately $800 million in milestone payments to ENTRA1, with total obligations estimated near $3.4 billion before NuScale's reactor-sale economics are disclosed.

Analysis

SMR is best viewed as a financing-dependent development asset rather than a near-term nuclear equipment supplier. The key valuation disconnect is that commercial progress may create a substantial cash obligation before it establishes a contracted revenue stream or unit economics; therefore, a headline contract can be simultaneously bullish for sentiment and dilutive for intrinsic value. The market is likely to trade a TVA-related announcement as de-risking in the first days, but the subsequent focus should shift to cash burn, incremental equity issuance, module pricing, and gross-margin disclosure over the following 1-3 quarters.

The second-order beneficiary of sustained AI-driven baseload demand is more likely the existing nuclear ecosystem than SMR: BWXT captures nuclear-component demand with operating earnings, GEV benefits from grid and power-equipment bottlenecks, while CEG and VST monetize tight power markets immediately. SMR's commercial partner structure appears to leave shareholders exposed to milestone funding while limiting certainty around conversion into customer orders. That asymmetry makes the equity particularly vulnerable if management cannot quantify per-module margin, customer deposits, and working-capital needs alongside any definitive agreement.

Consensus may be too bearish on the probability of sharp, event-driven rallies: a binding agreement or federal support could produce a 30-50% squeeze regardless of fundamentals, given the stock's history as an AI-power proxy. But this is not equivalent to a durable rerating. Over 6-18 months, the equity needs evidence that project economics support returns above its cost of capital without repeated share issuance; absent that evidence, dilution can absorb positive nuclear-demand narratives and cap upside.

The thesis is falsified by disclosure of firm module orders with meaningful customer prepayments, a credible price floor rather than a maximum sale price, and demonstrated gross-margin/FCF guidance that funds obligations without material new equity. Conversely, a further capital raise before an order, a delay in definitive contracting, or disclosure that the customer retains broad purchase flexibility should reassert the development-stage valuation discount.

Key Decisions for Investors

• Use any TVA/ENTRA1-driven rally to initiate or add to a tactical SMR short only after the initial headline reaction stabilizes; target a 3-6 month horizon and size modestly due to squeeze risk. A practical risk stop is a sustained move above the post-announcement high accompanied by disclosed customer deposits or binding module-volume commitments.
• Express the relative-value view through long BWXT / short SMR over 6-12 months. BWXT offers operating exposure to nuclear buildout while SMR remains dependent on commercialization proof; reassess if SMR provides auditable module-margin guidance and non-dilutive funding for its contractual obligations.
• For AI-power demand exposure, prefer CEG or VST for near-term power-price sensitivity and GEV for grid-capex exposure rather than treating SMR as a direct data-center power beneficiary. This reduces execution risk while retaining the structural theme over 12-18 months.
• Do not buy SMR outright ahead of a prospective definitive agreement without verifying three items: customer prepayment terms, enforceable minimum module purchases, and the financing plan for milestone payments. A positive agreement lacking these terms is a sentiment catalyst, not an investable earnings catalyst.
• Monitor quarterly share count, unrestricted liquidity, cash used in operations, and any revision to expected module economics. Material dilution or a higher cash-use run rate before a firm order supports the short thesis; a funded order backlog with disclosed attractive unit margins invalidates it.